X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs SUVEN LIFE - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. SUVEN LIFE WOCKHARDT LTD./
SUVEN LIFE
 
P/E (TTM) x -18.1 20.5 - View Chart
P/BV x 3.0 3.8 78.2% View Chart
Dividend Yield % 1.1 1.0 112.5%  

Financials

 WOCKHARDT LTD.   SUVEN LIFE
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
SUVEN LIFE
Mar-16
WOCKHARDT LTD./
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs1,129339 333.5%   
Low Rs627144 434.2%   
Sales per share (Unadj.) Rs363.139.2 925.3%  
Earnings per share (Unadj.) Rs-20.47.5 -274.0%  
Cash flow per share (Unadj.) Rs-7.08.8 -79.5%  
Dividends per share (Unadj.) Rs10.002.00 500.0%  
Dividend yield (eoy) %1.10.8 137.5%  
Book value per share (Unadj.) Rs301.849.0 616.0%  
Shares outstanding (eoy) m110.55127.28 86.9%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.46.2 39.3%   
Avg P/E ratio x-42.932.4 -132.7%  
P/CF ratio (eoy) x-125.927.5 -457.5%  
Price / Book Value ratio x2.94.9 59.0%  
Dividend payout %-48.926.8 -182.5%   
Avg Mkt Cap Rs m97,06330,732 315.8%   
No. of employees `0006.81.0 709.4%   
Total wages/salary Rs m9,665416 2,321.1%   
Avg. sales/employee Rs Th5,931.85,236.1 113.3%   
Avg. wages/employee Rs Th1,428.1436.5 327.2%   
Avg. net profit/employee Rs Th-334.0995.5 -33.5%   
INCOME DATA
Net Sales Rs m40,1464,995 803.7%  
Other income Rs m1,143194 590.4%   
Total revenues Rs m41,2895,189 795.7%   
Gross profit Rs m1281,233 10.4%  
Depreciation Rs m1,489167 890.7%   
Interest Rs m2,25354 4,156.3%   
Profit before tax Rs m-2,4721,205 -205.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-211255 -82.8%   
Profit after tax Rs m-2,260950 -238.0%  
Gross profit margin %0.324.7 1.3%  
Effective tax rate %8.521.2 40.4%   
Net profit margin %-5.619.0 -29.6%  
BALANCE SHEET DATA
Current assets Rs m46,1604,986 925.8%   
Current liabilities Rs m19,2581,042 1,847.8%   
Net working cap to sales %67.079.0 84.9%  
Current ratio x2.44.8 50.1%  
Inventory Days Days10161 165.2%  
Debtors Days Days9439 240.3%  
Net fixed assets Rs m40,1653,126 1,285.1%   
Share capital Rs m553127 434.2%   
"Free" reserves Rs m32,8143,717 882.7%   
Net worth Rs m33,3676,236 535.0%   
Long term debt Rs m31,903432 7,379.8%   
Total assets Rs m89,6878,079 1,110.1%  
Interest coverage x-0.123.2 -0.4%   
Debt to equity ratio x1.00.1 1,379.3%  
Sales to assets ratio x0.40.6 72.4%   
Return on assets %012.4 -0.1%  
Return on equity %-6.815.2 -44.5%  
Return on capital %-0.318.9 -1.8%  
Exports to sales %087.5 0.0%   
Imports to sales %012.2 0.0%   
Exports (fob) Rs mNA4,371 0.0%   
Imports (cif) Rs mNA611 0.0%   
Fx inflow Rs m9,1214,666 195.5%   
Fx outflow Rs m2,133942 226.4%   
Net fx Rs m6,9883,724 187.6%   
CASH FLOW
From Operations Rs m-2,695922 -292.3%  
From Investments Rs m-6,863-619 1,108.1%  
From Financial Activity Rs m12,545-698 -1,796.2%  
Net Cashflow Rs m3,010-396 -760.8%  

Share Holding

Indian Promoters % 74.5 63.4 117.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.0 -  
FIIs % 7.7 0.0 -  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 36.5 42.2%  
Shareholders   67,757 37,287 181.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   CADILA HEALTHCARE  J.B.CHEMICALS  MERCK LTD  BIOCON LTD  FULFORD INDIA  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Crash in Bitcoin, Correction in MidCap and SmallCap Indices and Top Stocks in Action Today(Pre-Open)

The past year has seen the BSE MidCap and BSE SmallCap indices surging by 43.1% and 57.1% respectively. Taking a two year view these indices have produced mind-boggling return of 75.3% .

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jan 16, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - TTK HEALTHCARE COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS